Last updated:
Author(s):
James Russ-Silsby, Kashyap A Patel, Thomas W Laver, Gareth Hawkes, Matthew B Johnson, Matthew N Wakeling, Prashant P Patil, Andrew T Hattersley, Sarah E Flanagan, Michael N Weedon, Elisa De Franco
Publish date:
28 August 2023
Journal:
Diabetes
PubMed ID:
37639628

Abstract

ONECUT1 (also known as HNF6) is a transcription factor involved in pancreatic development and β-cell function. Recently, biallelic variants in ONECUT1 were reported as a cause of neonatal diabetes mellitus (NDM) in two subjects, and missense monoallelic variants were associated with type 2 diabetes and possibly maturity-onset diabetes of the young (MODY). Here we examine the role of ONECUT1 variants in NDM, MODY, and type 2 diabetes in large international cohorts of subjects with monogenic diabetes and >400,000 subjects from UK Biobank. We identified a biallelic frameshift ONECUT1 variant as the cause of NDM in one individual. However, we found no enrichment of missense or null ONECUT1 variants among 484 individuals clinically suspected of MODY, in whom all known genes had been excluded. Finally, using a rare variant burden test in the UK Biobank European cohort, we identified a significant association between heterozygous ONECUT1 null variants and type 2 diabetes (P = 0.006) but did not find an association between missense variants and type 2 diabetes. Our results confirm biallelic ONECUT1 variants as a cause of NDM and highlight monoallelic null variants as a risk factor for type 2 diabetes. These findings confirm the critical role of ONECUT1 in human β-cell function.

ARTICLE HIGHLIGHTS:

Related projects

Our research question is `what are the genetic factors that predispose individuals to type 2 diabetes and what are the genetic factors that mean some…

Institution:
University of Exeter, Great Britain

Our question is `what are the genetic factors that lead to altered height, weight, BMI, waist-circumference and adiposity in today?s environment?? We will identify…

Institution:
University of Exeter, Great Britain

Our project aims to use the data from UK Biobank to maximise NHS patient benefit. The majority of research projects that combine DNA and health…

Institution:
University of Exeter, Great Britain

All projects